Lombard Odier Transatlantic’s Dr. Reddy's Laboratories RDY Stock Holding History

Lombard Odier Transatlantic’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$39K	Hold	4,150	–	–	0.04%	103
2016 Q2	$43K	Hold	4,150	–	–	0.05%	92
2016 Q1	$38K	Hold	4,150	–	–	0.04%	100
2015 Q4	$38K	Hold	4,150	–	–	0.03%	108
2015 Q3	$53K	Hold	4,150	–	–	0.06%	81
2015 Q2	$46K	Hold	4,150	–	–	0.04%	91
2015 Q1	$47K	Hold	4,150	–	–	0.04%	102
2014 Q4	$42K	Buy	+4,150	New	+$43.7K	0.04%	98

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lombard Odier Transatlantic's RDY Position: Q3 2016 in Review

Lombard Odier Transatlantic held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2016 at 4,150 shares worth $39K. The position accounts for 0.04% of the portfolio, ranked #103.

Lombard Odier Transatlantic first reported a position in RDY in Q4 2014 and has held it in 8 quarters since. The position peaked at $53K in Q3 2015. 156 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

Lombard Odier Transatlantic held 4,150 shares of Dr. Reddy's Laboratories worth $39K as of Q3 2016.
Lombard Odier Transatlantic left its Dr. Reddy's Laboratories share count unchanged in Q3 2016.
Dr. Reddy's Laboratories made up 0.04% of Lombard Odier Transatlantic's portfolio in Q3 2016, its #103 holding.
Lombard Odier Transatlantic first reported a position in Dr. Reddy's Laboratories in Q4 2014 and has held it in 8 quarters since.
Lombard Odier Transatlantic's Dr. Reddy's Laboratories position peaked at $53K in Q3 2015.
156 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q3 2016, filed 14 Nov 2016.